INFINITUM ASSET MANAGEMENT, LLC

Holdings History for ArriVent BioPharma, Inc. - Common Stock, $0.0001 Par Value per Share (AVBP)

Symbol: AVBP on Nasdaq
Investment type: Equity / Common Stock, $0.0001 Par Value per Share
Latest Disclosed Shares Owned: 4,123,923 shares
Security Ownership %: 9.9%

Shares, Excluding Options vs Price

Value, Excluding Options

INFINITUM ASSET MANAGEMENT, LLC ownership in ArriVent BioPharma, Inc. Common Stock, $0.0001 Par Value per Share (AVBP)

17 Feb 2026 - INFINITUM ASSET MANAGEMENT, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,123,923 shares of ArriVent BioPharma, Inc. Common Stock, $0.0001 Par Value per Share (AVBP). This represents 9.9% ownership of the company. In their previous filing dated 13 Aug 2025, INFINITUM ASSET MANAGEMENT, LLC had reported owning 3,418,923 shares, indicating an increase of +21%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
INFINITUM ASSET MANAGEMENT, LLC	9.9%	0%	$90,602,588	4,123,923	+705,000	+21%	$21.97	13G/A	31 Dec 2025	17 Feb 2026, 16:34
INFINITUM ASSET MANAGEMENT, LLC	9.9%		$75,318,874	3,418,923			$22.03	13G	01 May 2025	13 Aug 2025, 18:00
INFINITUM ASSET MANAGEMENT, LLC	6.1%		$43,019,075	2,066,238			$20.82	13G	01 May 2025	15 May 2025, 16:36

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	12%	+0.76%	$82,973,331	4,123,923	+255,000	+6.6%	$20.12	Q4 2025
30 Sep 2025	13%	+1.5%	$71,381,629	3,868,923	+450,000	+13%	$18.45	Q3 2025
30 Jun 2025	16%	+6.5%	$74,429,954	3,418,923	+1,352,685	+65%	$21.77	Q2 2025
31 Mar 2025	13%	+2.6%	$38,204,741	2,066,238	+422,315		$18.49	Q1 2025
31 Dec 2024	23%	0%	$43,794,108	1,643,923	0		$26.64	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.